Barclays’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Buy |
+9,412
| New | +$30K | ﹤0.01% | 4028 |
|
|
2021
Q4 | – | Sell |
-1,416
| Closed | -$26K | – | 3590 |
|
|
2021
Q3 | $26K | Buy |
1,416
+1,003
| +243% | +$18.4K | ﹤0.01% | 3563 |
|
|
2021
Q2 | $10K | Sell |
413
-857
| -67% | -$20.8K | ﹤0.01% | 3857 |
|
|
2021
Q1 | $33K | Buy |
+1,270
| New | +$33K | ﹤0.01% | 3591 |
|
|
2020
Q3 | – | Sell |
-459
| Closed | -$10K | – | 3835 |
|
|
2020
Q2 | $10K | Buy |
+459
| New | +$10K | ﹤0.01% | 3646 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3816 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | – | – | 4074 |
|
|
2019
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4289 |
|
|
2019
Q1 | – | Sell |
-1,776
| Closed | -$39K | – | 4332 |
|
|
2018
Q4 | $39K | Sell |
1,776
-100
| -5% | -$2.2K | ﹤0.01% | 3236 |
|
|
2018
Q3 | $44K | Hold |
1,876
| – | – | ﹤0.01% | 3774 |
|
|
2018
Q2 | $41K | Sell |
1,876
-477
| -20% | -$10.4K | ﹤0.01% | 3349 |
|
|
2018
Q1 | $61K | Buy |
+2,353
| New | +$61K | ﹤0.01% | 3412 |
|
|
2017
Q3 | – | Sell |
-2,051
| Closed | -$140K | – | 4077 |
|
|
2017
Q2 | $140K | Buy |
2,051
+1,663
| +429% | +$114K | ﹤0.01% | 2618 |
|
|
2017
Q1 | $25K | Buy |
388
+285
| +277% | +$18.4K | ﹤0.01% | 3309 |
|
|
2016
Q4 | $7K | Buy |
103
+97
| +1,617% | +$6.59K | ﹤0.01% | 3356 |
|
|
2016
Q3 | $0 | Sell |
6
-17
| -74% | – | ﹤0.01% | 4002 |
|
|
2016
Q2 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 3425 |
|